Liver Growth Factor Induces Glia-Associated Neuroprotection in an In Vitro Model of Parkinson´s Disease

Parkinson’s disease is a neurodegenerative disorder characterized by the progressive death of dopaminergic (DA) neurons in the substantia nigra (SN), which leads to a loss of the neurotransmitter dopamine in the basal ganglia. Current treatments relieve the symptoms of the disease, but none stop or...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonzalo-Gobernado, Rafael, Reimers, Diana, Casarejos, María José, Calatrava Ferreras, Lucía, Vallejo-Muñoz, Manuela, Jiménez-Escrig, Adriano, Diaz-Gil, Juan José, Ulzurrun de Asanza, Gonzalo M., Bazán, Eulalia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287666/
https://www.ncbi.nlm.nih.gov/pubmed/32455921
http://dx.doi.org/10.3390/brainsci10050315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287666/
https://www.ncbi.nlm.nih.gov/pubmed/32455921
http://dx.doi.org/10.3390/brainsci10050315

Ejemplares similares